Tarsons Products Limited
₹311.20
-2.03%
Delayed · cached 15 min
Peer comparison
| Company | Price↕ | Market Cap↕ | P/E↕ | P/B↕ | ROE %↕ | ROCE %↕ | Div yield %↕ | Valuation |
|---|---|---|---|---|---|---|---|---|
| Poly Medicure Limited | ₹ 1,738.50 | ₹ 17,622 Cr | 55.86 | 5.67 | 9.02 | 12.50 | 0.00 | Above FV |
| Fischer Medical Venture L | ₹ 35.87 | ₹ 2,455 Cr | 79.71 | 6.02 | 8.59 | 11.40 | 0.00 | Above FV |
| Q-Line Biotech Limited | — | ₹ 1,694 Cr | 30.00 | — | 25.90 | 22.50 | 0.00 | — |
| Tarsons Products Limited | ₹ 311.20 | ₹ 1,656 Cr | 148.90 | 2.59 | 2.44 | 4.59 | 0.00 | Above FV |
| Laxmi Dental Limited | ₹ 202.84 | ₹ 1,116 Cr | 36.09 | 4.59 | 14.80 | 14.90 | 0.00 | Above FV |
| Vasa Denticity Limited | ₹ 563.10 | ₹ 977 Cr | 93.69 | 5.64 | 6.68 | 8.61 | 0.00 | Above FV |
| Osel Devices Limited | — | ₹ 662 Cr | 22.70 | 3.26 | 18.70 | 23.40 | 0.00 | — |
| Nureca Limited | ₹ 332.75 | ₹ 333 Cr | 73.45 | 1.76 | 1.12 | 3.30 | 0.00 | Above FV |
| Qms Medical Allied S Ltd | ₹ 157.98 | ₹ 305 Cr | 30.15 | 5.32 | 10.40 | 13.20 | 0.00 | Above FV |
| Aprameya Engineering Ltd | — | ₹ 221 Cr | 43.30 | 3.19 | 7.63 | 12.80 | 0.00 | — |
| Vaidya Sane Ayur Lab Ltd | ₹ 148.00 | ₹ 156 Cr | 18.39 | 1.78 | 12.00 | 15.10 | 0.00 | Above FV |
| Mohini Health&Hygiene Ltd | ₹ 57.05 | ₹ 104 Cr | — | 1.17 | -8.87 | -3.83 | 0.00 | — |
Price, market cap, P/E, P/B and dividend yield reflect the live quote (delayed, cached 15 min); ROE/ROCE from reported financials. The highlighted row is the current company. Click a column header to sort. Educational data only.
How to read the peer comparison
This table places the company beside others in the same industry on a few common measures. Comparison adds context that a single company's numbers cannot give on their own.
- Valuation multiples like P/E and P/B are most meaningful within the same industry, because different industries naturally trade at different levels. Comparing a company only to its peers is more useful than to the whole market.
- Return measures (ROE, ROCE) show how efficiently each company turns capital into profit. A company well ahead of or behind its peers here is worth understanding.
- No single column decides anything. A beginner reads the row across — valuation, returns, and size together — and treats the highlighted current company as one data point among its peers.
- Use the sortable headers to rank peers on any measure, but remember that "cheaper" or "higher" on one metric is a starting question, not an answer.
Educational only — not a recommendation to buy, sell, or hold any security.